WASHINGTON — In order to create guidelines for digital therapeutics, consistent and validated evidence must be presented, according to a panel at the Digital Therapeutics Alliance Summit.Currently, speakers said, the assessments for digital therapeutics vary, which has led to a range of ways to create guidelines.